Pitfalls in the beam modelling process of Monte Carlo calculations for proton pencil beam scanning.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 1 2 2020
medline: 28 2 2020
entrez: 1 2 2020
Statut: ppublish

Résumé

Monte Carlo (MC) simulations substantially improve the accuracy of predicted doses. This study aims to determine and quantify the uncertainties of setting up such a MC system. Doses simulated with two Geant4-based MC calculation codes, but After the independent beam modelling of both systems in water (resulting in excellent range agreement) range differences of up to 3.6/4.8 mm (1.5% of total range) in bone/brain-like tissues were found, which resulted from the use of different mean water ionisation potentials during the energy tuning process. When repeating using a common definition of water, ranges in bone/brain agreed within 0.1 mm and gamma-analysis (global 1%,1mm) showed excellent agreement (>93%) for all patient fields. However, due to a lack of modelling of proton fluence loss in the descriptive pre-absorber, differences of 7% in absolute dose between the pre-absorber definitions were found. This study quantifies the influence of using different water ionisation potentials during the MC beam modelling process. Furthermore, when using a descriptive pre-absorber model, additional Faraday cup or ionisation chamber measurements with pre-absorber are necessary. This is the first study quantifying the uncertainties caused by the MC beam modelling process for proton pencil beam scanning, and a more detailed beam modelling process for MC simulations is proposed to minimise the influence of critical parameters.

Identifiants

pubmed: 32003576
doi: 10.1259/bjr.20190919
pmc: PMC7066947
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190919

Références

Phys Med. 2018 Jun;50:7-12
pubmed: 29891097
Phys Med Biol. 2018 Jul 16;63(14):145016
pubmed: 29726402
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1157-1164
pubmed: 26025779
Phys Med Biol. 1996 Jan;41(1):111-24
pubmed: 8685250
Phys Med Biol. 2015 Jan 21;60(2):633-45
pubmed: 25549079
Phys Med Biol. 2004 Oct 7;49(19):4543-61
pubmed: 15552416
Med Phys. 1998 May;25(5):656-61
pubmed: 9608475
Phys Med Biol. 2018 Feb 09;63(4):045003
pubmed: 29339570
Phys Med Biol. 1999 Jan;44(1):185-205
pubmed: 10071883
Phys Med Biol. 2018 Aug 23;63(17):175001
pubmed: 30010613
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1249-59
pubmed: 16798417
Phys Med Biol. 2000 Feb;45(2):459-78
pubmed: 10701515
Technol Cancer Res Treat. 2016 Dec;15(6):NP35-NP46
pubmed: 26596915
Phys Med Biol. 2012 Jun 7;57(11):R99-117
pubmed: 22571913
Phys Med Biol. 2011 Aug 21;56(16):5203-19
pubmed: 21791731
Phys Med Biol. 2015 Nov 7;60(21):8601-19
pubmed: 26501569
Med Phys. 2012 Nov;39(11):6818-37
pubmed: 23127075
Phys Med Biol. 2009 Jun 7;54(11):N205-15
pubmed: 19436099
Phys Med Biol. 2014 Aug 7;59(15):4007-31
pubmed: 24990623
Phys Med Biol. 2010 Feb 7;55(3):711-21
pubmed: 20071752
Phys Med Biol. 2017 Sep 12;62(19):7659-7681
pubmed: 28749373
Phys Med Biol. 2012 Oct 21;57(20):6381-93
pubmed: 22996039
Phys Med Biol. 2015 Jul 21;60(14):5627-54
pubmed: 26146956

Auteurs

Carla Winterhalter (C)

Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
Department of Physics, ETH Zürich, Switzerland.

Adam Aitkenhead (A)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

David Oxley (D)

Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.

Jenny Richardson (J)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.

Damien C Weber (DC)

Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
Department of Radiation Oncology, University Hospital of Bern, Bern, Switzerland.
Department of Radiation Oncology, University Hospital of Zürich, Zürich, Switzerland.

Ranald I MacKay (RI)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

Antony J Lomax (AJ)

Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
Department of Physics, ETH Zürich, Switzerland.

Sairos Safai (S)

Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH